Cargando…

Follistatin-like 1 protects against hypoxia-induced pulmonary hypertension in mice

Pulmonary hypertension (PH) remains a life-limiting disease characterized by pulmonary vascular remodelling due to aberrant proliferation and migration of pulmonary artery smooth muscle cells (PASMCs), thus leading to raised pulmonary arterial pressure and right ventricular hypertrophy. Secreted gly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wei, Wang, Wang, Liu, Jie, Li, Jinna, Wang, Juan, Zhang, Yunxia, Zhang, Zhifei, Liu, Yafei, Jin, Yankun, Li, Jifeng, Cao, Jie, Wang, Chen, Ning, Wen, Wang, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374469/ https://www.ncbi.nlm.nih.gov/pubmed/28361925 http://dx.doi.org/10.1038/srep45820

Ejemplares similares

Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway
por: Jin, Yan-Kun, et al.
Publicado: (2018)

Blocking follistatin-like 1 attenuates bleomycin-induced pulmonary fibrosis in mice
por: Dong, Yingying, et al.
Publicado: (2015)

Follistatin-Like 1: A Potential Mediator of Inflammation in Obesity
por: Fan, Nengguang, et al.
Publicado: (2013)

Follistatin like-1 aggravates silica-induced mouse lung injury
por: Fang, Yinshan, et al.
Publicado: (2017)

Expression and functional analysis of the Follistatin‐like 3 (FSTL3) gene in the sheep ovary during the oestrous cycle
por: He, Jianning, et al.
Publicado: (2020)

Follistatin-Like 1 Protects against Doxorubicin-Induced Cardiomyopathy through Upregulation of Nrf2
por: Zhao, Yintao, et al.
Publicado: (2020)

The BMP inhibitor follistatin-like 1 (FSTL1) suppresses cervical carcinogenesis
por: Zhao, Chenjing, et al.
Publicado: (2023)

Follistatin-like 1 deficiency impairs T cell development to promote lung metastasis of triple negative breast cancer
por: Ma, Jie, et al.
Publicado: (2021)

Epigenetic inactivation of follistatin-like 1 mediates tumor immune evasion in nasopharyngeal carcinoma
por: Zhou, Xiaoying, et al.
Publicado: (2016)

Transcriptional activation of follistatin by Nrf2 protects pulmonary epithelial cells against silica nanoparticle-induced oxidative stress
por: Lin, Chen, et al.
Publicado: (2016)

Aldehyde dehydrogenase 2 protects against oxidative stress associated with pulmonary arterial hypertension
por: Xu, Tao, et al.
Publicado: (2016)

Analysis of the expression and mechanism of follistatin‑like protein 1 in cervical cancer
por: Liu, Zhen, et al.
Publicado: (2023)

Endothelial extracellular vesicles induce acute lung injury via follistatin-like protein 1
por: Yuan, Hao-Xiang, et al.
Publicado: (2023)

Deficiency of Follistatin-Like Protein 1 Accelerates the Growth of Breast Cancer Cells at Lung Metastatic Sites
por: Zhang, Ying, et al.
Publicado: (2018)

Are follistatin-like protein 1 and follistatin-like protein 3 associated with inflammatory processes in patients with familial Mediterranean fever?
por: Kaplan, Huseyin, et al.
Publicado: (2023)

Follistatin Like 5 (FSTL5) inhibits epithelial to mesenchymal transition in hepatocellular carcinoma
por: Zhang, Deng-Yong, et al.
Publicado: (2020)

Role of follistatin-like 1 levels and functions in calcific aortic stenosis
por: Zhang, Qianru, et al.
Publicado: (2023)

Identification and Validation of Autophagy-Related Genes in Chronic Obstructive Pulmonary Disease
por: Sun, Shulei, et al.
Publicado: (2021)

Follistatin-like protein 1 functions as a potential target of gene therapy in proliferative diabetic retinopathy
por: Niu, Rui, et al.
Publicado: (2021)

Follistatin-like 1 in development and human diseases
por: Mattiotti, Andrea, et al.
Publicado: (2018)

Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinoma
por: Liu, Yan, et al.
Publicado: (2018)

A spatiotemporal barrier formed by Follistatin is required for left–right patterning
por: Fu, Xin-Xin, et al.
Publicado: (2023)

Follistatin‐like 1 promotes cardiac fibroblast activation and protects the heart from rupture
por: Maruyama, Sonomi, et al.
Publicado: (2016)

Follistatin-like protein 1 is elevated in systemic autoimmune diseases and correlated with disease activity in patients with rheumatoid arthritis
por: Li, Dawei, et al.
Publicado: (2011)

Microarray Analysis and Detection of MicroRNAs Associated with Chronic Thromboembolic Pulmonary Hypertension
por: Miao, Ran, et al.
Publicado: (2017)

The protective role of EP300 in monocrotaline-induced pulmonary hypertension
por: Yang, Lei, et al.
Publicado: (2023)

Follistatin like-1 (Fstl1) is required for the normal formation of lung airway and vascular smooth muscle at birth
por: Liu, Xue, et al.
Publicado: (2017)

Follistatin-Like Proteins: Structure, Functions and Biomedical Importance
por: Parfenova, Olga K., et al.
Publicado: (2021)

Effects of chrysin (5,7-dihydroxyflavone) on vascular remodeling in hypoxia-induced pulmonary hypertension in rats
por: Li, Xian-Wei, et al.
Publicado: (2015)

Polo-like kinase 1 promotes pulmonary hypertension
por: Chen, Rongrong, et al.
Publicado: (2023)

Follistatin-like protein 1: a serum biochemical marker reflecting the severity of joint damage in patients with osteoarthritis
por: Wang, Yuji, et al.
Publicado: (2011)

Endogenous Follistatin-like 1 guarantees the immunomodulatory properties of mesenchymal stem cells during liver fibrotic therapy
por: Zheng, Xiaohong, et al.
Publicado: (2022)

Blockade of JAK2 protects mice against hypoxia‐induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation
por: Zhang, Lei, et al.
Publicado: (2020)

Potential therapeutic targets for hypoxia-induced pulmonary artery hypertension
por: Dong, Li, et al.
Publicado: (2014)

Follistatin-Like 1 Attenuation Suppresses Intervertebral Disc Degeneration in Mice through Interacting with TNF-α and Smad Signaling Pathway
por: Wang, Shaoyi, et al.
Publicado: (2021)

Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model
por: Shen, Han, et al.
Publicado: (2019)

Growth Differentiation Factor 9 (GDF9) Suppresses Follistatin and Follistatin-Like 3 Production in Human Granulosa-Lutein Cells
por: Shi, Feng-Tao, et al.
Publicado: (2011)

Circulating biomarkers in chronic thromboembolic pulmonary hypertension
por: Zhang, Meng, et al.
Publicado: (2019)

Roles of follistatin-like protein 3 in human non-tumor pathophysiologies and cancers
por: Tian, Shifeng, et al.
Publicado: (2022)

Determination of PKC isoform-specific protein expression in pulmonary arteries of rats with chronic hypoxia-induced pulmonary hypertension
por: Shi, Yiwei, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_tsucqin0iklb4j8rukdp37uqs1